Teknova to Participate in Upcoming Investor Conference
01 September 2022 - 6:01AM
Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider
of critical reagents for the discovery, development, and
commercialization of drug therapies, novel vaccines, and molecular
diagnostics, today announced that the Company will participate in
the following upcoming investor conference.
Morgan Stanley 20th Annual Global
Healthcare Conference September 12-14, 2022 New York,
NY
Stephen Gunstream, Teknova’s President and Chief
Executive Officer, and Matt Lowell, Teknova’s Chief Financial
Officer, will participate in a fireside chat at 7:20 a.m. ET, on
Tuesday, September 13, 2022. Gunstream and Lowell plan to discuss
Company highlights, their product portfolio, market trends, key
growth drivers, and long-term market opportunities.
The live audio webcast for this conference may be
accessed from the Investor Relations section of the Company’s
website: https://ir.teknova.com/. The webcast and transcript will
be available on the Company’s website for approximately 90 days
after the event.
About Teknova Teknova is
expediting clinical breakthroughs in life sciences by providing
custom products and reagents for drug therapies, novel vaccines,
and molecular diagnostics. With a focus on agility and
customization, Teknova delivers research-grade and GMP products,
including cell culture media and supplements, protein and nucleic
acid purification buffers, and molecular biology reagents for a
multitude of established and emerging applications, including cell
and gene therapy, mRNA therapeutics, genomics, and synthetic
biology. Teknova's proprietary processes enable the manufacture and
delivery of high-quality, custom, made-to-order products with short
turnaround times and at scale across all stages of development,
including commercialization.
Investor Contacts
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-637-1100
Sara Michelmore
MacDougall Advisors
smichelmore@macdougall.bio
+1 781-235-3060
Media Contact
Jenn Henry
Senior Vice President, Marketing
jenn.henry@teknova.com
+1 831-313-1259
Alpha Teknova (NASDAQ:TKNO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alpha Teknova (NASDAQ:TKNO)
Historical Stock Chart
From Apr 2023 to Apr 2024